FDA approves Alzheimer’s drug donanemab after months of delay
The Food and Drug Administration gave approval Tuesday to a closely watched Alzheimer’s drug, concluding that the benefits of modestly […]
Alzheimers
FDA Approves Eli Lilly’s Alzheimer’s Drug That Slows Memory Decline
The Food and Drug Administration approved a new Alzheimer’s drug from Eli Lilly that has been shown in clinical trials
FDA approves new Alzheimer’s treatment, donanemab from Eli Lilly
The Food and Drug Administration on Tuesday approved a new Alzheimer’s treatment called donanemab, paving the way for the third
New drug approved for early Alzheimer’s
The Food and Drug Administration on Tuesday approved a new drug for Alzheimer’s disease, the latest in a new class